International Journal of Cancer Management

Published by: Kowsar

Effect of Simultaneous Treatment with Royal Jelly and Doxorubicin on the Survival of the Prostate Cancer Cell Line (PC3): An In Vitro Study

Rouzbeh Mohammadi Abandansari 1 , Hadi Parsian 2 , Faranak Kazerouni 1 , Roghaye Porbagher 2 , Ebrahim Zabihi 2 and Ali Rahimipour 1 , *
Authors Information
1 Department of Medical Laboratory Technology, Faculty of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Article information
  • International Journal of Cancer Management: April 2018, 11 (4); e13780
  • Published Online: April 28, 2018
  • Article Type: Research Article
  • Received: June 28, 2017
  • Revised: November 27, 2017
  • Accepted: March 5, 2018
  • DOI: 10.5812/ijcm.13780

To Cite: Mohammadi Abandansari R, Parsian H, Kazerouni F, Porbagher R, Zabihi E, et al. Effect of Simultaneous Treatment with Royal Jelly and Doxorubicin on the Survival of the Prostate Cancer Cell Line (PC3): An In Vitro Study, Int J Cancer Manag. 2018 ; 11(4):e13780. doi: 10.5812/ijcm.13780.

Abstract
Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300. doi: 10.3322/caac.20073. [PubMed: 20610543].
  • 2. van Brussel JP, van Steenbrugge GJ, Romijn JC, Schroder FH, Mickisch GH. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins. Eur J Cancer. 1999;35(4):664-71. [PubMed: 10492644].
  • 3. Van Brussel JP, Jan Van Steenbrugge G, Van Krimpen C, Bogdanowicz JF, Van Der Kwast TH, Schroder FH, et al. Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer. J Urol. 2001;165(1):130-5. doi: 10.1097/00005392-200101000-00032. [PubMed: 11125381].
  • 4. Devaraj S, Moffett BS. A Guide to Therapeutic Drug Monitoring. 2015.
  • 5. Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, et al. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics. 2011;21(7):440-6. doi: 10.1097/FPC.0b013e32833ffb56. [PubMed: 21048526].
  • 6. Sanchez C, Mendoza P, Contreras HR, Vergara J, McCubrey JA, Huidobro C, et al. Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs. Prostate. 2009;69(13):1448-59. doi: 10.1002/pros.20991. [PubMed: 19496068].
  • 7. Mofid B, Rezaeizadeh H, Termos A, Rakhsha A, Mafi AR, Taheripanah T, et al. Effect of Processed Honey and Royal Jelly on Cancer-Related Fatigue: A Double-Blind Randomized Clinical Trial. Electron Physician. 2016;8(6):2475-82. doi: 10.19082/2475. [PubMed: 27504161].
  • 8. Premratanachai P, Chanchao C. Review of the anticancer activities of bee products. Asian Pac J Trop Biomed. 2014;4(5):337-44. doi: 10.12980/APJTB.4.2014C1262. [PubMed: 25182716].
  • 9. Musa M, Nasir NF, Thirumulu KP. Evaluation of royal jelly as an alternative to fetal bovine serum in cell culture using cell proliferation assays and live cell imaging. Afr J Tradit Complement Altern Med. 2014;11(1):148-55. doi: 10.4314/ajtcam.v11i1.23. [PubMed: 24653569].
  • 10. Nakaya M, Onda H, Sasaki K, Yukiyoshi A, Tachibana H, Yamada K. Effect of royal jelly on bisphenol A-induced proliferation of human breast cancer cells. Biosci Biotechnol Biochem. 2007;71(1):253-5. doi: 10.1271/bbb.60453. [PubMed: 17213647].
  • 11. Garcia-Amoedo LH, Almeida-Muradian L. Physicochemical composition of pure and adulterated royal jelly. Química Nova. 2007;30(2):257-9. doi: 10.1590/s0100-40422007000200002.
  • 12. Sabatini AG, Marcazzan GL, Caboni MF, Bogdanov S, Almeida-Muradian L. Quality and standardisation of royal jelly. J ApiProd ApiMed Sci. 2009;1(1):1-6. doi: 10.3896/ibra.4.1.01.04.
  • 13. Okic-Djordjevic I, Trivanovic D, Krstic J, Jaukovic A, Mojsilovic S, Santibanez JF, et al. GE132+Natural: Novel promising dietetic supplement with antiproliferative influence on prostate, colon, and breast cancer cells. J BUON. 2013;18(2):504-10. [PubMed: 23818369].
  • 14. Moutsatsou P, Papoutsi Z, Kassi E, Heldring N, Zhao C, Tsiapara A, et al. Fatty acids derived from royal jelly are modulators of estrogen receptor functions. PLoS One. 2010;5(12). e15594. doi: 10.1371/journal.pone.0015594. [PubMed: 21203528].
  • 15. Mahmoud K, Anas T. The role of honey with royal jelly in protecting the graafian follicles from the toxicity of the adriamycin drug. Int J Pharm Pharm Sci. 2015;7(4):376-85.
  • 16. Hosseini S, Delerezh N, Afzal Ahangaran N. The effects of royal jelly on in-vitro cytotoxicity of K562 cells and peripheral blood mononuclear cells. Armaghane Dnesh. 2014;18(11):869-78. Persian.
  • 17. Samia A. E. F , Othman E. O , Esraa A. B , Soheir A. A. E . The protective role of royal jelly against mutagenic effect of adriamycin and gamma radiation separately and in combination. Trends Appl Sci Res. 2008;3(4):303-18. doi: 10.3923/tasr.2008.303.318.
  • 18. Melliou E, Chinou I. Chemistry and bioactivity of royal jelly from Greece. J Agric Food Chem. 2005;53(23):8987-92. doi: 10.1021/jf051550p. [PubMed: 16277392].
  • 19. Townsend GF, Brown WH, Felauer EE, Hazlett B. Studies on the in vitro antitumor activity of fatty acids. IV. The esters of acids closely related to 10-hydroxy-2-decenoic acids from royal jelly against transplantable mouse leukemia. Can J Biochem Physiol. 1961;39:1765-70. doi: 10.1139/o61-195. [PubMed: 13922208].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments